Mike Collins: “It is that, and I think the interesting thing is the middleman who produces nothing on their own. That is the thing.…”

“It is that, and I think the interesting thing is the middleman who produces nothing on their own. That is the thing. They don't produce anything in this. They are simply--you know, I think I will just sort of describe it like I see it in northeast Georgia. It is like a tick on the back of a dog. They just simply suck profit off and do not do what you exactly just said. They don't do what they just said. I mean, Caterpillar. You brought up Caterpillar. I will bring you some numbers with Caterpillar. Caterpillar started moving away from PBMs. They suspected that they could save as much as, in a quarter, $150 million in drug prices being spent inefficiently. They went back and did their own formularies. They worked this out so that they are on this straight, and just--the company saved 5- to $10 million per year in just cholesterol-lowering statins alone, one of the most widely prescribed medications, just in that right there. When you see how PBMs claim to save money, you look at the Caterpillar model. There are other models out there that are finally looking at this and saying: We can do this in a better way. And I appreciate your input tonight. I think that has been--you are just highlighting this that there are ways to do this. This is not the only way.…”